Clinical trials: Gynecologic Oncology Patient
Gynecologic Cancer, Urologic Cancer
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
Cancer treatment is multidisciplinary and may include radiotherapy. Treatment-related complications represent a burden for patients and the healthcare system.
- Conditions
- Gynecologic Cancer, Urologic Cancer, Breast Cancer
- Trial name
- NCT07416630
- Testing
- Web-Based Application for PROM Monitoring During Radiotherapy
- Where
- Slovenia
- Volunteers
- 30 people
- Sponsor
- Institute of Oncology Ljubljana
Gynecologic Cancer
Massage, Oncology, Pain, Anxiety, Feasibility
The goal of this clinical trial is to determine the feasibility of studying massage therapy in patients with gynecologic cancers while receiving infusion treatments.
- Trial name
- IMPACT (NCT07502157)
- Testing
- Massage Therapy, Attention Control
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Jill Cole
Breast Cancer, Gynecologic Cancer
Female Cancer Patients' Preference For Sexual Health Interventions
The purpose of this study is to survey female cancer patients' awareness of and preference for methods to improve sexual health.
- Trial name
- NCT01084642
- Where
- United States
- Volunteers
- 229 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Nursing, Gynecological Cancers
Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients
To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery.
- Conditions
- Nursing, Gynecological Cancers, Psycho-Oncology
- Trial name
- NCT07745478
- Testing
- E-MOTE group
- Where
- Taiwan
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Gynecologic Cancer
Relationships Among Physical and Psychological Status, Social Support, Resource Utilization, Supportive Care Needs in Patients With Gynecological Cancer
With the advancement of medical treatments and under the trend of prolonging the survival rate of gynecological cancer patients, the use of social resources and the need for supportive care are particularly important! In the…
- Trial name
- NCT05776693
- Where
- Taiwan
- Volunteers
- 200 people
- Sponsor
- National Taiwan University Hospital
Advanced Malignant Female Reproductive System Neoplasm
An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care
This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from where it first started to nearby…
- Trial name
- NCT06182332
- Testing
- Electronic Health Record Review, Internet-Based Intervention
- Where
- United States
- Volunteers
- 221 people
- Sponsor
- Mayo Clinic
Gynecologic Cancer, Frailty
Cognitive and Physical Frailty as Predictors of Decision Satisfaction in Geriatric Gynecologic Oncology
This prospective observational study aims to evaluate the association between preoperative cognitive function, measured by the Montreal Cognitive Assessment (MoCA), and physical frailty, assessed using the Clinical Frailty Scale…
- Conditions
- Gynecologic Cancer, Frailty, Cognitive Impairment, Geriatric Oncology
- Trial name
- GYNCOGFRAIL (NCT07085000)
- Testing
- No Intervention - Observational Assessment
- Where
- Turkey (Türkiye)
- Volunteers
- 68 people
- Sponsor
- Izmir City Hospital
Metastatic Breast Cancer, Breast Tumor
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
The primary objective is to examine the impact on progression-free survival of targeted therapy for breast cancer suggested by proteomic and genomic profiling.
- Conditions
- Metastatic Breast Cancer, Breast Tumor, Advanced Gynecologic Cancer
- Trial name
- NCT02470819
- Testing
- Genetic profiling
- Where
- United States
- Sponsor
- Avera McKennan Hospital & University Health Center
Neoplasms, Ovarian Neoplasms
Biobehavioral Intervention in Gynecologic Oncology Patients
Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions.
- Conditions
- Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulva
- Trial name
- NCT02454036
- Testing
- BBI intervention
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Rachel Miller
Gynecologic Cancer
Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
Gynger is a no profit, observational study, composed of a retrospective cohort (A) and a prospective cohort (B). The primary aim of this trial is to describe gene profile of Italian gynecological cancers patients, through the…
- Trial name
- GYNGER (NCT05733793)
- Testing
- NGS tests
- Where
- Italy
- Volunteers
- 300 people
- Sponsor
- National Cancer Institute, Naples
Survivorship, Breast Cancer
Accessible Cancer Care to Enable Support for Survivors Programme
In Singapore, cancer patients are not consistently assessed for unmet survivorship care needs and systematically identified for subsequent referral to useful care services.
- Conditions
- Survivorship, Breast Cancer, Gynecologic Cancer
- Trial name
- ACCESS (NCT04014309)
- Testing
- Supportive and survivorship care program, Usual care
- Where
- Singapore
- Volunteers
- 226 people
- Sponsor
- National University of Singapore
Pain
Effect of Lubricating Gel for Pain Relief During Speculum Examination in Gynecologic Oncology Patients
Pelvic examination, an important part of gynecologic oncology patients to help detect cancers recurrence or infections.Despite its importance, many women are reluctant and anxious about the procedure because of fear, as well as…
- Trial name
- NCT01987440
- Testing
- lubricating gel
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people
- Sponsor
- Erzincan Military Hospital
Endometrial Neoplasms, Uterine Cervical Neoplasms
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
The purpose of this study is to create a tissue bank of gynecologic cancers and normal tissue for the study of cancer in order to better understand the changes occurring on a molecular level (DNA, RNA, protein) that lead to the…
- Conditions
- Endometrial Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Leiomyoma
- Trial name
- NCT00299481
- Where
- 7 sites in United States
- Volunteers
- 7,000 people
- Sponsor
- U.S. Army Medical Research and Development Command
Endometrial Cancer, Endometrial Adenocarcinoma
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
IMGN853 is designed to inhibit cell division and cell growth of folate receptor 1 (FRα)-expressing tumor cells. The purpose of this study is to test the safety of IMGN853 and bevacizumab and see what effects (good and bad) that…
- Conditions
- Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
- Trial name
- NCT03836157
- Testing
- Mirvetuximab Soravtansine, Bevacizumab
- Where
- United States
- Sponsor
- University of Oklahoma
Ovarian Sarcoma, Ovarian Stromal Cancer
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
This randomized phase II trial studies how well psychosexual intervention works in patients with stage I-III gynecologic or breast cancer. Psychosexual intervention may improve sexual and psychosocial function.
- Conditions
- Ovarian Sarcoma, Ovarian Stromal Cancer, Stage I Uterine Sarcoma, Stage I Vaginal Cancer
- Trial name
- NCT01764802
- Testing
- behavioral, psychological or informational intervention
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Ohio State University Comprehensive Cancer Center
Fallopian Tube Cancer, Female Reproductive Cancer
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
This phase II trial is studying how well ziv-aflibercept works in treating patients with locally advanced, unresectable or metastatic gynecologic soft tissue sarcoma.
- Conditions
- Fallopian Tube Cancer, Female Reproductive Cancer, Ovarian Carcinosarcoma, Ovarian Sarcoma
- Trial name
- NCT00390234
- Testing
- ziv-aflibercept
- Where
- 16 sites in United States, Canada
- Volunteers
- 63 people
- Sponsor
- National Cancer Institute (NCI)
Gynecologic Cancer, Myoma
Pilot Study to Evaluate the Knowledge and Understanding on Surgery for Patients With Hysterectomy
The purpose of this study is to assess the level of knowledge of surgery for women who underwent hysterectomy
- Trial name
- NCT02103933
- Volunteers
- 200 people
- Sponsor
- National Cancer Center, Korea
Ankle Motion, Gynecologic Neoplasm
Functional Training for the Prevention of Deep Venous Thrombosis
This study aims to analyze the post-operative functional training on the prevention of deep venous thrombosis (DVT) in the patients who have accepted major surgeries for the gynecological malignancies.
- Conditions
- Ankle Motion, Gynecologic Neoplasm, Deep Venous Thrombosis, Abdominal Breathing
- Trial name
- NCT03740633
- Testing
- passive ankle pump motions on the day of surgery, active ankle pump motions and abdominal breathing training on the 1-3 day after the surgery, Regular care
- Where
- China
- Volunteers
- 398 people
- Sponsor
- Lei Li
Gastrointestinal Cancer, Gynecologic Cancer
BOLSTER: Learning New Skills to Thrive
This research study is evaluating a new program called Building Out Lifelines for Safety, Trust, Empowerment, and Renewal or (BOLSTER), which was designed to support participants with a gynecological or gastrointestinal cancer…
- Conditions
- Gastrointestinal Cancer, Gynecologic Cancer, Advanced Cancer
- Trial name
- BOLSTER (NCT06936878)
- Testing
- BOLSTER Program
- Where
- 2 sites in United States
- Volunteers
- 600 people
- Sponsor
- Dana-Farber Cancer Institute
Sarcoma,Soft Tissue, Gynecologic Cancer
Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)
Catequentinib (AL3818, Anlotinib) has been developed in a variety of clinical studies as single agents or in combination with others.
- Trial name
- NCT05612191
- Testing
- AL3818
- Sponsor
- Advenchen Laboratories, LLC